وصلة ذهبية بخمسة أطراف لتوصيل الكأس الكهربائية EMG 1 إلى 2

معلومات اساسية

• متاح على:
• English
• العربية

The EarlyTect Colon Cancer Test is a highly efficient diagnostic tool that has been authorized by the Korea Ministry of Food and Drug Safety. It has undergone rigorous clinical trials at renowned medical institutions such as Yonsei Medical Center, Severance Hospital, and Severance Check-up Center. These trials involved 585 individuals aged between 30 and 80 years. The results have demonstrated that this test has a remarkable accuracy of 90% in detecting colorectal cancer (CRC) by analyzing fecal DNA.

Utilizing qualitative real-time PCR technology, the EarlyTect Colon Cancer Test measures the levels of methylated Syndecan-2 (SDC2), which is a biomarker directly associated with the existence of precancerous CRC lesions in stool DNA. It is important to note that this test is not designed to confirm the presence of colorectal cancer. However, if the test yields a positive result, it indicates the potential for CRC or precancerous lesions of CRC.

Product Standard:
- Cancer Type: Colorectal Cancer
- Targeted Subject: Asymptomatic individuals undergoing colorectal cancer screening
- Biomarker: SDC2 methylation marker

The price and terms of transaction can be negotiated. Please feel free to request a quote for further information on this product.